 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
^ Top
N
Neurology and Neurosurgery: Clinical & Review Criteria Guidelines for ...
Neurology: Clinical Cases Uncovered
Neuroma Global Clinical Trials Review, Q4, 2010
Neuromuscular Disorders
Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016
Neuropathic Pain - Pipeline Review, Q4 2010
Neuropathic Pain Market Forecast
Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecas...
Neuropathic Pain: A Global Survey of Treatment Practices
Neuropathic Pain: Competing Treatments and Market Entry Considerations...
Neuropathic Pain: Emerging Drugs and Current Treatment Practices
Neuropathic Pain: Treatments and Prescribing Practices - A Global Surv...
Neuropathy Therapy Area Pipeline Report
Neuroprotective Agents: Eighth International Neuroprotection Society M...
Neurostimulation - Advanced Technologies and Global Market (2009 - 201...
Neutropenia - Pipeline Assessment and Market Forecasts to 2017
Neutropenia - Pipeline Review, Q1 2011
Neutropenia - Pipeline Review, Q4 2010
Neutropenia Global Clinical Trials Review, Q4, 2010
Neutropenia Therapy Area Pipeline Report
Nevus Global Clinical Trials Review, Q1, 2011
New Approaches to Gaining Market Access for Pharmaceuticals: Pricing &...
New Approaches to Pharma R&D: Evolving Strategies to Rejuvenate R&D Ef...
New Directions in Organizational Psychology and Behavioral Medicine
New Drug Approval in Japan
New Drug Approval in the European Union
New Drug Futures 2009
New Drug Review and Outlook 2011
New Drug Review and Outlook 2011/New Medical Device Review and Outlook...
New Frontiers in Asymmetric Catalysis
New Mexico Cancer Care Alliance - Developmental Therapeutics Review - ...
New Nanomaterials for Forensics & Diagnostics
New Pharmaceutical Product Launch Strategies - Initiating Market Entry...
New Research into Prescribing Practices
New Strategies in Pharmaceutical Academic-Industry Collaborations
New Zealand Pharmaceuticals and Healthcare Report Q1 2012
New Zealand Pharmaceuticals and Healthcare Report Q4 2011
Newly Competitive Gaucher’s Disease Marketplace: Showcases Strategies ...
NEWSWEEK Green Rankings Business Report 2010-2011 — Pharmaceuticals
Next Generation Protein Engineering and Drug Design: Strategies to boo...
Nigeria - Pharmaceutical Industry Overview
Nigeria Brand Report: Consumers of Headache Tablets and Powders
Nigeria Pharmaceuticals and Healthcare Report Q1 2008
Nigeria Pharmaceuticals and Healthcare Report Q1 2009
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Nigeria Pharmaceuticals and Healthcare Report Q1 2011
Nigeria Pharmaceuticals and Healthcare Report Q1 2012
Nigeria Pharmaceuticals and Healthcare Report Q2 2008
Nigeria Pharmaceuticals and Healthcare Report Q2 2009
Nigeria Pharmaceuticals and Healthcare Report Q2 2010
Nigeria Pharmaceuticals and Healthcare Report Q2 2011
Nigeria Pharmaceuticals and Healthcare Report Q3 2008
Nigeria Pharmaceuticals and Healthcare Report Q4 2008
Nigeria Pharmaceuticals and Healthcare Report Q4 2010
Nocturia - Pipeline Review, H2 2011
Nocturia - Pipeline Review, Q2 2011
Nocturia - Pipeline Review, Q4 2010
Nocturnal Enuresis Therapeutics - Pipeline Assessment and Market Forec...
Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2011
Non-Alcoholic Steatohepatitis - Pipeline Review, Q1 2011
Non-Hodgkin Lymphoma - Pipeline Review, Q4 2010
Non-Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010
Non-Hodgkin Lymphoma Therapy Area Pipeline Report
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forec...
Non-Hodgkin's Lymphoma (NHL) - Pipeline Assessment and Market Forecast...
Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Ma...
Non-pharmacy OTC market in Poland 2011, Development forecasts for 2011...
Non-Small Cell Lung Cancer (NSCLC) - Pipeline Assessment and Market Fo...
Non-Small Cell Lung Cancer - Pipeline Review, Q4 2010
Non-Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010
Nonalcoholic Steatohepatitis (NASH) - Pipeline Review, Q4 2010
Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment...
Nonalcoholic Steatohepatitis Therapeutics - Pipeline Assessment and Ma...
Nonmelanomatous Skin Cancer - Pipeline Review, Q4 2010
Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010
Nordic Life Science Industry Guide 2008
North America Pharmaceuticals Sectors : A Company and Industry Analysi...
North American and Western Europe Oral Solid Drug Dosage Excipients
North American Brain Tumor Consortium - Developmental Therapeutics Rev...
North American Fine Chemicals Market: Investment Analysis
North American OE Suspension Systems and Modules Markets
North American Pharmaceutical Market: Strategic Assessments of Leading...
North China Pharmaceutical: A Company Analysis
Norway Drug Patent Inventor Report - 2012
Norway Pharmaceutical Market Analysis, 2010-2014
Nosocomial Infection - Pipeline Review, Q4 2010
Notes for the MRCGP: A curriculum based guide to the AKT, CSA and WBPA...
Novartis: Performace, Capabilities, Goals and Strategies in the Worldw...
Novartis: Performance, Capabilities, Goals and Strategies in the World...
Novasep: Performance, Capabilities, Goals and Strategies in the Worldw...
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Fu...
Novel Targeted Therapies Hold the Promise of Cure for Parkinson's Dise...
NovoLog (Type 2 Diabetes) - Analysis and Forecasts to 2020
Nuclear and Particle Physics: An Introduction, 2nd Edition
Nuclear Medicine - A Global Update of Market Trends & Opportunities
Nuclear Medicine - Global Strategic Business Report
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
Nurses, HIV, and Complementary Medicine: More linked than you think!. ...
Nutraceuticals in China and Japan: Emerging Opportunities and their Cr...
Nutraceuticals Market Assessment 2008
Nutraceuticals Market in India 2010
Nutraceuticals Market to 2017 - Food Additives such as Omega-3 Fatty A...
Nutritional and Dietary Supplements Market in China - Demand for Herba...
Nutritional and Dietary Supplements Market in India - Demand, Opportun...
Nutritional and Dietary Supplements Market in Japan
Nutritional and Dietary Supplements Market in the US - Opportunities a...
Nutritional Supplements - Edition 2010
^ Top
O
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare M...
Obesity - Pipeline Review, H2 2011
Obesity - Pipeline Review, Q1 2011
Obesity - Pipeline Review, Q4 2010
Obesity Drug Discoveries: what the future holds
Obesity Drug Discoveries: what the future holds + Obesity Tracker
Obesity Drug Markets in the US and EU: Analysis of Product Pipelines a...
Obesity Global Clinical Trials Review, Q1, 2011
Obesity Therapy Area Pipeline Report
Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment...
Obsessive-Compulsive Disorder Therapy Area Pipeline Report
Obstructive Sleep Apnea Global Clinical Trials Review, Q4, 2010
Occupational and Environmental Lung Diseases: Diseases from Work, Home...
Ocular Hypertension - Pipeline Review, H2 2011
Ocular Hypertension - Pipeline Review, Q4 2010
Ocular Hypertension Global Clinical Trials Review, Q2, 2011
Ocular Hypertension Therapy Area Pipeline Report
Ocular Inflammation - Pipeline Review, Q1 2011
Ocular Inflammation Therapy Area Pipeline Report
Odense University Hospital - Developmental Therapeutics Review - Q1 20...
Off-Label Prescribing: Overcoming the Reimbursement Barrier
Ohio State University Comprehensive Cancer Center - Developmental Ther...
Old People Care in Institutions
Older People Coping With Chronic Pain. Edition No. 1
Oligodendroglioma - Pipeline Review, Q4 2010
Oligodendroglioma Global Clinical Trials Review, Q4, 2010
Oligonucleotide Therapeutics: The Next Big Thing
Oman Pharmaceuticals & Healthcare Report Q1 2008
Oman Pharmaceuticals and Healthcare Report Q1 2009
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2011
Oman Pharmaceuticals and Healthcare Report Q1 2012
Oman Pharmaceuticals and Healthcare Report Q2 2009
Oman Pharmaceuticals and Healthcare Report Q3 2007
Oman Pharmaceuticals and Healthcare Report Q3 2011
Oncology Market in India to 2017 - Limited Patient Affordability for H...
Online Pharmaceutical Directory for Contract Manufacturing Organizatio...
Onychomycosis - Pipeline Review, Q4 2010
Onychomycosis – Executive Market Summary 2011
Onychomycosis Therapy Area Pipeline Report
Open-Angle Glaucoma - Pipeline Review, H1 2012
Open-Angle Glaucoma - Pipeline Review, Q1 2011
Open-Angle Glaucoma - Pipeline Review, Q3 2011
Open-Angle Glaucoma Global Clinical Trials Review, Q2, 2011
Operational Efficiency in Clinical Trials
Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Repor...
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report...
Ophthalmology and Optometry Conjunctivitis
Ophthalmology and Optometry Dry Eyes
Ophthalmology and Optometry Eye Infections
Ophthalmology and Optometry Glaucoma
Ophthalmology and Optometry Macular Degeneration
Ophthalmology and Optometry Ocular Inflammation
Ophthalmology and Optometry Pipeline Databook
Ophthalmology Drug Futures: Sight Preservation in Chronic Eye Diseases...
Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors ...
Opium Addiction - Pipeline Review, Q4 2010
Opium Addiction Therapy Area Pipeline Report
Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil...
Opportunities and Challenges for Generic Drugs in Australia
Opportunities and Challenges for Generic Drugs in the UK 2007
Opportunities and Challenges in Emerging U.S. Geriatric Drug Markets
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactiv...
Opportunities Assessment for Diabetes Therapeutics - Australia
Opportunities Assessment for Diabetes Therapeutics Market-Taiwan
Opportunities Assessment for Diabetes Therapeutics: South Korea
Opportunities for European Pharmaceutical and Biotechnology Companies ...
Opportunities for Monoclonal Antibodies: Where Companies Are Spending ...
Opportunities in Emerging Markets - Central and Eastern Europe, Russia...
Opportunities in Emerging Markets - Latin America, Brazil, and Mexico
Opportunities in Emerging Markets - Newly Industrialized Asia (South K...
Opportunities in Indian Pharma Sector
Opportunities in Menopausal Treatments: Will New Therapies Overtake Ho...
Opportunities in Orphan Drugs: Strategies for developing maximum retur...
Opportunities in the Pharmacotherapy of Addiction
Opportunity Analysis of the U.S. Tele-Health Solutions Market
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
Optic Nerve Injury - Pipeline Review, H2 2011
Optic Nerve Injury - Pipeline Review, Q2 2011
Optimizing Clinical Trials through IT
Optimizing Partnerships with Contract Organizations: Effective Managem...
Optimizing Pipeline Performance - Maximizing Future Sales Opportunitie...
Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition
Optoelectronic Sensors
Oral Bioavailability: Basic Principles, Advanced Concepts, and Applica...
Oral Cancer - Pipeline Review, Q4 2010
Oral Cancer Global Clinical Trials Review, Q4, 2010
Oral contraceptive pills: Advances and progress over the last 50 years...
Oral Mucositis - Pipeline Review, H2 2011
Oral Mucositis - Pipeline Review, Q1 2011
Oral Mucositis - Pipeline Review, Q4 2010
Oral-lyn (Oral Recosulin) - R & D Biopharmaceutical & Pharmaceutical P...
Oregon Health and Science University - Developmental Therapeutics Revi...
Organic Reaction Mechanisms 2006
Organic Syntheses, Volume 86
Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2012
Organophosphate And Carbamate Poisoning - Pipeline Review, Q1 2011
Organophosphate And Carbamate Poisoning - Pipeline Review, Q3 2011
Oropharyngeal Cancer Global Clinical Trials Review, Q4, 2010
Oropharynx Cancer - Pipeline Review, Q4 2010
Oropharynx Cancer Global Clinical Trials Review, Q4, 2010
Orphan Disease Series - Glaucoma: Can Orphan-Drug Status Offer an Entr...
Orphan Drug Markets in Europe: Key Developments and the Strategies of ...
Orphan Drug Report 2011
Orphan Drug Report 2012
Orphan Drug Strategies
Orphan Drug Trends 2011
Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help O...
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Acc...
Orphan Drugs Pipeline Analysis: Wider Incentives Encourage Orphan Drug...
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) - Develo...
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Fore...
Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017
Osteoarthritis - Pipeline Review, H2 2011
Osteoarthritis - Pipeline Review, Q4 2010
Osteoarthritis Pain - Pipeline Review, Q4 2010
Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Fore...
Osteoarthritis Therapy Area Pipeline Report
Osteoarthritis: Atlas of Investigation Diagnosis and Management
Osteonecrosis Global Clinical Trials Review, H2, 2011
Osteopenia - Pipeline Review, H2 2011
Osteopenia - Pipeline Review, Q4 2010
Osteopenia Global Clinical Trials Review, H2 2011
Osteopenia Global Clinical Trials Review, Q2, 2011
Osteoporosis - Pipeline Assessment and Market Forecasts to 2017
Osteoporosis - Pipeline Review, H2 2011
Osteoporosis - Pipeline Review, Q4 2010
Osteoporosis Drug Market- Global And China Market Analysis, Size, Tren...
Osteoporosis Global Clinical Trials Review, H2, 2011
Osteoporosis Global Clinical Trials Review, Q1, 2011
Osteoporosis Therapeutics - A Global Market Perspective
Osteoporosis Therapeutics - Global Strategic Business Report
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts t...
Osteoporosis Therapy Area Pipeline Report
Osteoporosis: An Atlas of Investigation and Management
Osteosarcoma - Pipeline Review, Q4 2010
Osteosarcoma Global Clinical Trials Review, Q4, 2010
OTC Company Profile - Rochel Holding AG
OTC Company Profile: Otsuka Pharmaceutical
OTC Drug Market in India 2011
OTC Healthcare Company Profile - Aventis
OTC Healthcare Company Profile - Boehringer
OTC Healthcare Company Profile - Bristol Myer Squibb
OTC Healthcare Company Profile - Glaxo SmithKline Plc
OTC Healthcare Company Profile - NuSkin Enterprises
OTC Healthcare Company Profile - Sanofi Synthelabo France SA
OTC Healthcare in Algeria
OTC Healthcare in Ecuador
OTC Healthcare in Macedonia
OTC Healthcare in The United Arab Emirates
OTC Market in Central and Eastern Europe 2010: Comparative Analysis an...
OTC Market in Poland 2010: Switch Strategies and Development Forecasts...
OTC Market in Poland 2010: Switch Strategies and Development Forecasts...
OTC Obesity in Austria
OTC Obesity in France
OTC Obesity in Germany
OTC Obesity in Greece
OTC Obesity in Philippines
OTC Obesity in Poland
OTC Obesity in Portugal
OTC Obesity in Singapore
OTC Obesity in Spain
OTC Obesity in USA
OTC Opportunities in Europe, the US and Japan: Key Trends, Leading Pla...
OTC Pharmaceuticals & Pharmacy Retailing in China 2010: A Market Analy...
OTC Pharmaceuticals - Australia - A Snapshot (2010)
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Gui...
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
OTC Pharmaceuticals - North America (NAFTA) Industry Guide
OTC Pharmaceuticals - Scandinavia Industry Guide
OTC Pharmaceuticals - South Africa - A Snapshot (2010)
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
OTC Pharmaceuticals in Asia-Pacific
OTC Pharmaceuticals in Australia
OTC Pharmaceuticals in Belgium
OTC Pharmaceuticals in Brazil
OTC Pharmaceuticals in Canada
OTC Pharmaceuticals in China
OTC Pharmaceuticals in Denmark
OTC Pharmaceuticals in Egypt
OTC Pharmaceuticals in Europe
OTC Pharmaceuticals in France
OTC Pharmaceuticals in Germany
OTC Pharmaceuticals in Hungary
OTC Pharmaceuticals in India
OTC Pharmaceuticals in Israel
OTC Pharmaceuticals in Italy
OTC Pharmaceuticals in Japan
OTC Pharmaceuticals in Mexico
OTC Pharmaceuticals in Norway
OTC Pharmaceuticals in Poland
OTC Pharmaceuticals in Russia
OTC Pharmaceuticals in Saudi Arabia
OTC Pharmaceuticals in Singapore
OTC Pharmaceuticals in South Africa
OTC Pharmaceuticals in South Africa
OTC Pharmaceuticals in South Korea
OTC Pharmaceuticals in Spain
OTC Pharmaceuticals in Sweden
OTC Pharmaceuticals in Taiwan
OTC Pharmaceuticals in the Czech Republic
OTC Pharmaceuticals in the Netherlands
OTC Pharmaceuticals in the United Kingdom
OTC Pharmaceuticals in the United States
OTC Pharmaceuticals in United Arab Emirates
OTC Pharmaceuticals Market Report
OTC Pharmaceuticals Market Report 2008
OTC Pharmaceuticals Market Report 2010
OTC Pharmaceuticals Market Report 2011
OTC Pharmaceuticals: Advanced Emerging Markets (Brazil, Hungary, Mexic...
OTC Pharmaceuticals: Global Industry Almanac
OTC Pharmaceuticals: Global Industry Guide
OTC Review and Outlook 2011
Otelixizumab (GSK2136525, TRX4, ChAglyCD3) - R & D Biopharmaceutical &...
Other Brain-Related Conditions Global Clinical Trials Review, Q4, 2010...
Other Metabolic Disorders Global Clinical Trials Review, Q2, 2011
Otitis Media - Pipeline Review, H2 2011
Otitis Media - Pipeline Review, Q1 2011
Otitis Media - Pipeline Review, Q4 2010
Otitis Media Global Clinical Trials Review, H2, 2011
Otitis Media Global Clinical Trials Review, Q4, 2010
Ottawa Hospital Research Institute - Developmental Therapeutics Review...
Outlook of China Drug Formulation Market
Outsourcing Chemistry Services Made Easy
Outsourcing Clinical Development
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative...
Outsourcing in Clinical Trials New Jersey
Ovarian Cancer Global Clinical Trials Review, Q4, 2010
Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts...
Ovarian Cancer Therapy Area Pipeline Report
Over-the-Counter Pharmaceuticals in China: A Market Analysis 2006
Over-the-Counter Pharmaceuticals in China: Company Profiles 2006
Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market...
Overactive Bladder - Pipeline Review, H2 2011
Overactive Bladder - Pipeline Review, Q1 2011
Overactive Bladder - Pipeline Review, Q4 2010
Overactive Bladder Global Clinical Trials Review, Q2, 2011
Overactive Bladder Therapy Area Pipeline Report
Overview of Pharmaceutical and Medical Devices Industry in Central and...
Overview of Pharmaceutical and Medical Devices Industry in Russia and ...
Overview of the Bulgarian and Romanian Pharmaceutical Markets
Overview of the European Drug Discovery Market
^ Top
P
Paediatric Clinical Trials
Paediatric Gastroenterology: An Atlas of Investigation and Management
Paediatric Hypertension
Paget's Disease of Bone (PDB) Therapeutics - Pipeline Assessment and M...
Paget's disease of Bone - Pipeline Assessment and Market Forecasts to ...
Paget's Disease Therapy Area Pipeline Report
Pain Drugs: Problems and Opportunities
Pain in Osteoarthritis
Pain Management - Evaluation and Treatment Issues, 2nd Edition (2011 u...
Pain Management Therapeutics Market to 2017 - Price Competition to Int...
Pain Therapeutics - Drugs, Markets and Companies
Pain Therapy Area Pipeline Report
Pakistan Pharmaceuticals & Healthcare Report Q1 2008
Pakistan Pharmaceuticals and Healthcare Report Q1 2010
Pakistan Pharmaceuticals and Healthcare Report Q1 2011
Pakistan Pharmaceuticals and Healthcare Report Q1 2012
Pakistan Pharmaceuticals and Healthcare Report Q2 2010
Pakistan Pharmaceuticals and Healthcare Report Q4 2010
Pakistan Pharmaceuticals and Healthcare Report Q4 2011
Pancreatic Cancer - Pipeline Assessment and Market Forecasts to 2017
Pancreatic cancer Clinical Trials Review, Q4, 2010
Pancreatic Cancer Drugs - Global Strategic Business Report
Pancreatic Cancer Therapy Area Pipeline Report
Pancreatic Fistula Global Clinical Trials Review, Q1, 2011
Pancreatitis Global Clinical Trials Review, Q1, 2011
Panic Disorder Therapy Area Pipeline Report
Para IV Pipeline Analysis of Indian Pharma Companies
Paradigm Shift in R&D from Small Molecules to Biologics and Need for M...
Parenteral Nutrition Market to 2017 - Home Care Sector To Witness Stro...
Parenting Acting-out Adolescents. Edition No. 1
Parkinson Disease Therapy Area Pipeline Report
Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2...
Parkinson's Disease Biomarkers: Vital Tools for Neuroprotectants
Parkinson's Disease Global Clinical Trials Review, Q4, 2010
Parkinson's Disease Presents Lucrative Market Opportunities
Parkinson's Disease: Non-Motor and Non-Dopaminergic Features
Part 11 and Drug Development: A Q&A Reference Guide
Partial Seizure - Pipeline Review, Q4 2010
Partnering Agreements in Pharma and Biotech Yearbook 2010
Partnering Agreements with Abbott 2010
Partnering Agreements with Actavis 2010
Partnering Agreements with Alcon 2010
Partnering Agreements with Allergan 2010
Partnering Agreements with Amgen 2010
Partnering Agreements with Astellas 2010
Partnering Agreements with AstraZeneca 2010
Partnering Agreements with Baxter 2010
Partnering Agreements with Bayer 2010
Partnering Agreements with BigPharma
Partnering Agreements with Biogen Idec 2010
Partnering Agreements with Boehringer Ingelheim 2010
Partnering Agreements with Bristol-Myers Squibb 2010
Partnering Agreements with Cephalon 2010
Partnering Agreements with Chugai 2010
Partnering Agreements with CSL 2010
Partnering Agreements with Daiichi Sankyo 2010
Partnering Agreements with Dainippon Sumitomo 2010
Partnering Agreements with Eisai 2010
Partnering Agreements with Eli Lilly 2010
Partnering Agreements with Forest 2010
Partnering Agreements with Genentech 2010
Partnering Agreements with Genzyme 2010
Partnering Agreements with Gilead 2010
Partnering Agreements with GlaxoSmithKline 2010
Partnering Agreements with Hospira 2010
Partnering Agreements with Johnson & Johnson 2010
Partnering Agreements with Lundbeck 2010
Partnering Agreements with Menarini 2010
Partnering Agreements with Merck & Co 2010
Partnering Agreements with Merck Serono 2010
Partnering Agreements with Mitsubishi Tanabe 2010
Partnering Agreements with Mylan 2010
Partnering Agreements with Novartis 2010
Partnering Agreements with Novo Nordisk 2010
Partnering Agreements with Nycomed 2010
Partnering Agreements with Otsuka 2010
Partnering Agreements with Pfizer 2010
Partnering Agreements with Ratiopharm 2010
Partnering Agreements with Roche 2010
Partnering Agreements with Sanofi-Aventis 2010
Partnering Agreements with Servier 2010
Partnering Agreements with Shire 2010
Partnering Agreements with Solvay 2010
Partnering Agreements with Takeda 2010
Partnering Agreements with Teva 2010
Partnering Agreements with UCB 2010
Partnering Agreements with Watson 2010
Partnering in the Global Generics Industry 2009: A guide to companies
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharm...
Patent Expiry Strategies of Big Pharma
Patent Law and Practice in Pharmaceuticals
Patent Protection Strategies: Maximising Product Revenues
Patent Strategies - Effective Strategies for Extension of Product Life...
Pathology Board Review Course
Patient and Investigator Recruitment Success
Patient Power Outlook 2001
Paving the Difficult Road to Universal Insurance Coverage: Spotlight o...
Pay-for-Delay: An Unsettled Future Lies Ahead
Payer Agreements: Splitting the Risk
Pediatric Cancer - Pipeline Review, Q4 2010
Pediatric Cancer Global Clinical Trials Review, Q4, 2010
Pediatric Drugs and Vaccines - Global Strategic Business Report
Pediatric Hematology and Oncology: Scientific Principles and Clinical ...
Pemphigus Vulgaris - Pipeline Review, Q4 2010
Penicillins and their Derivatives with a Penicillanic Acid Structure: ...
Penile Cancer Global Clinical Trials Review, Q4, 2010
Penn State University - Developmental Therapeutics Review - Q1 2011
People with COPD in their everyday life. Edition No. 1
Peptic Ulcer - Pipeline Review, H2 2011
Peptic Ulcer - Pipeline Review, Q2 2011
Peptic Ulcer - Pipeline Review, Q4 2010
Peptic Ulcer Global Clinical Trials Review, Q4, 2010
Peptic Ulcers Global Clinical Trials Review, H2, 2011
Perceived Stressors by High-Risk Pregnant Women on Bed Rest. Edition N...
Periodontal Disease - Drug Pipeline Analysis and Market Forecasts to 2...
Periodontal Disease - Pipeline Review, H2 2011
Periodontal Disease - Pipeline Review, Q1 2011
Periodontal Disease - Pipeline Review, Q4 2010
Periodontal Disease Global Clinical Trials Review, Q1, 2011
Periodontal Disease Therapeutics - Pipeline Assessment and Market Fore...
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market For...
Peripheral Arterial Disease - Pipeline Review, Q4 2010
Peripheral Arterial Disease Global Clinical Trials Review, Q4, 2010
Peripheral Arterial Disease Therapy Area Pipeline Report
Peripheral Neuropathy - Pipeline Review, Q4 2010
Peripheral Neuropathy and Neuropathic Pain 2008
Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and...
Peripheral Vascular Disease Therapy Area Pipeline Report
Peritoneal Cancer Global Clinical Trials Review, Q4, 2010
Peritonitis Global Clinical Trials Review, Q1, 2011
Personalised Medicine Market in Europe
Personalized Medicine
Personalized Medicine & Orphan Drugs Review and Outlook 2010
Personalized Medicine - Opening Doors and Overcoming Challenges
Personalized Medicine - Scientific and Commercial Aspects
Personalized Medicine Market - Advances in Human Genomics and Proteomi...
Personalized Medicine Market Analysis
Personalized Medicine Partnering Terms and Agreements
Pertussis - Pipeline Review, Q4 2010
Peru Pharmaceuticals and Healthcare Report Q1 2008
Peru Pharmaceuticals and Healthcare Report Q1 2009
Peru Pharmaceuticals and Healthcare Report Q1 2010
Peru Pharmaceuticals and Healthcare Report Q1 2011
Peru Pharmaceuticals and Healthcare Report Q2 2008
Peru Pharmaceuticals and Healthcare Report Q2 2009
Peru Pharmaceuticals and Healthcare Report Q3 2007
Peru Pharmaceuticals and Healthcare Report Q3 2008
Peru Pharmaceuticals and Healthcare Report Q3 2011
Peru Pharmaceuticals and Healthcare Report Q4 2008
Peru Pharmaceuticals and Healthcare Report Q4 2009
Peru Pharmaceuticals and Healthcare Report Q4 2011
PETHEMA - Developmental Therapeutics Review - Q1 2011
Pfizer: Performance, Capabilities, Goals and Strategies in the Worldwi...
Pfizer: Performance, Capabilities, Goals and Strategies in the Worldwi...
Pfizer: Pipeline, Products, Performance, Potential
Pharma & BioPharma Canada, Industry Guide 2011
Pharma and the Feds: Key Government Activities and How They Affect the...
Pharma Antes Up: Investment and Business Trends Driving Biotechnology
Pharma Bio World
Pharma Blogging: Speaking Out
Pharma Business Management in India
Pharma Goes Cloud Gazing (Analyst Opinion)
Pharma Industry Panel in Brazil
Pharma Industry Panel in Brazil
Pharma Industry Portal
Pharma Industry Statistics in India
Pharma Market Authorization Strategies: A Guide To Launching Drugs Qui...
Pharma Market Insights: Latin America
Pharma Marketing Excellence: Lessons from Experience
Pharma Marketing in Latin America
Pharma on Twitter: Developing a Presence
Pharma Packaging and Labelling Europe
Pharma Packaging and Labelling USA
Pharma Poland News
Pharma Poland Online
Pharma Pricing and Reimbursement Outlook: Optimizing Price and Market ...
Pharma Product Launches: Strategies for Success
Pharma Readiness for Personalized Medicine
Pharma Sales Force Innovations: Technology, Training and Rewards
Pharma Sales Forces: Mexico
Pharma Social Media Campaigns: Current Thinking and Future Outlook
Pharma YouTube Channels: Content and Comment
Pharma's Changing Business Strategies: Five Deadly Pharma Sins
Pharma's New Home Lies at the Corner of Facebook and Twitter (Strategi...
Pharma-Ecology: The Occurrence and Fate of Pharmaceuticals and Persona...
Pharma/Medical Device/Diagnostics Licensing and Collaborations – Evalu...
Pharma/PCP 2nd Edition - Global Review of Microbiology Testing in the ...
Pharmaceutical & Healthcare Annual Deals Analysis 2011
Pharmaceutical & Medicine Manufacturing in the US
Pharmaceutical & Medicines World Report
Pharmaceutical (Japan) - Portfolio Analysis
Pharmaceutical (Japan) - Portfolio Analysis
Pharmaceutical Alliance Management
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings,...
Pharmaceutical and Biomedical Project Management in a Changing Global ...
Pharmaceutical and Biotech Licensing Strategies - Driving Revenue thro...
Pharmaceutical and Medical Device Regulatory Affairs
Pharmaceutical and Medicine Manufacturing in China
Pharmaceutical and Medicine Manufacturing Industry in the U.S. and its...
Pharmaceutical and Toiletry Wholesaling in Australia
Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fak...
Pharmaceutical Applications of Raman Spectroscopy
Pharmaceutical Biotechnology: Concepts and Applications
Pharmaceutical Brand Lift - Marketing ROI and Budget Allocation
Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring R...
Pharmaceutical Branding Strategies: Thought Leader Perspectives On Bra...
Pharmaceutical Business Development and Licensing: Strengthening Pipel...
Pharmaceutical Calculations, 4th Edition
Pharmaceutical Cliff Diving - Assessing the Key Challenges that will R...
Pharmaceutical Companies 2000: Strategic Analysis and Future Perspecti...
Pharmaceutical Companies Performance Tables 2006
Pharmaceutical Companies Performance Tables 2010
Pharmaceutical Companies Performance: Winners and Losers in a recessio...
Pharmaceutical Companies: Current Status and Prospects for Generic Dru...
Pharmaceutical Company Influence on Nurse Practitioner Prescribing. Ed...
Pharmaceutical Company Outlook to 2014
Pharmaceutical Company Outlook to 2015
Pharmaceutical Contract Manufacturing - Global Market Trends
Pharmaceutical Contract Manufacturing - Global Strategic Business Repo...
Pharmaceutical Contract Manufacturing 2003 - Japan
Pharmaceutical Contract Manufacturing 2004
Pharmaceutical Contract Manufacturing 2005
Pharmaceutical Contract Manufacturing and API Sourcing In Central and ...
Pharmaceutical Contract Manufacturing and API Sourcing in Central Euro...
Pharmaceutical Contract Manufacturing and API Sourcing in Russia, Ukra...
Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets t...
Pharmaceutical Cost Containment in Europe: National Governments Tighte...
Pharmaceutical Counterfeiting in the EU: Where Are We Now?
Pharmaceutical Data Mining: Approaches and Applications for Drug Disco...
Pharmaceutical Deal Structures - The Essential Manual for Deal Makers
Pharmaceutical Digital Marketing and Social Media: Managing Growth, Mi...
Pharmaceutical Directory of China 2012
Pharmaceutical Directory of India 2012
Pharmaceutical Distribution in Europe: Pfizer Breaks the Mold
Pharmaceutical Distributors - Africa
Pharmaceutical Distributors - Algeria
Pharmaceutical Distributors - Armenia
Pharmaceutical Distributors - Asia
Pharmaceutical Distributors - Belarus
Pharmaceutical Distributors - Belgium
Pharmaceutical Distributors - Bulgaria
Pharmaceutical Distributors - China
Pharmaceutical Distributors - Croatia
Pharmaceutical Distributors - Czech Republic
Pharmaceutical Distributors - Denmark
Pharmaceutical Distributors - Eastern Europe
Pharmaceutical Distributors - Egypt
Pharmaceutical Distributors - Europe
Pharmaceutical Distributors - Finland
Pharmaceutical Distributors - France
Pharmaceutical Distributors - Germany
Pharmaceutical Distributors - Global
Pharmaceutical Distributors - Hong Kong
Pharmaceutical Distributors - India
Pharmaceutical Distributors - Iran
Pharmaceutical Distributors - Ireland
Pharmaceutical Distributors - Italy
Pharmaceutical Distributors - Japan
Pharmaceutical Distributors - Latvia
Pharmaceutical Distributors - Mexico
Pharmaceutical Distributors - Moldova
Pharmaceutical Distributors - Morocco
Pharmaceutical Distributors - Netherlands
Pharmaceutical Distributors - New Zealand
Pharmaceutical Distributors - Norway
Pharmaceutical Distributors - Poland
Pharmaceutical Distributors - Portugal
Pharmaceutical Distributors - Romania
Pharmaceutical Distributors - Russia
Pharmaceutical Distributors - San Marino
Pharmaceutical Distributors - Saudi Arabia
Pharmaceutical Distributors - Serbia
Pharmaceutical Distributors - Singapore
Pharmaceutical Distributors - Slovakia
Pharmaceutical Distributors - South Africa
Pharmaceutical Distributors - Spain
Pharmaceutical Distributors - Sri Lanka
Pharmaceutical Distributors - Sweden
Pharmaceutical Distributors - Switzerland
Pharmaceutical Distributors - Thailand
Pharmaceutical Distributors - Turkey
Pharmaceutical Distributors - Ukraine
Pharmaceutical Distributors - United Arab Emirates
Pharmaceutical Distributors - United Kingdom
Pharmaceutical Distributors - Western Europe
Pharmaceutical Growth Opportunities in the EU Accession States: Health...
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape...
Pharmaceutical Industry Dynamics 2010: Licensing Opportunities: Rheuma...
Pharmaceutical Industry in Belgium
Pharmaceutical Industry in Brazil
Pharmaceutical Industry in China
Pharmaceutical Industry in China
Pharmaceutical Industry in China - PEST Framework Analysis
Pharmaceutical Industry in China, 2004-2005
Pharmaceutical Industry in Czech Republic
Pharmaceutical Industry in Denmark
Pharmaceutical Industry in Dominican Republic: Business Report 2011
Pharmaceutical Industry in Germany
Pharmaceutical Industry in Ghana and Nigeria
Pharmaceutical Industry in Hungary
Pharmaceutical Industry in India - PEST Framework Analysis
Pharmaceutical Industry in India - Porter's Five Forces Strategy Analy...
Pharmaceutical Industry in Italy
Pharmaceutical Industry in Japan
Pharmaceutical Industry in Mexico
Pharmaceutical Industry in Norway
Pharmaceutical Industry in Poland
Pharmaceutical Industry in Russia
Pharmaceutical Industry in South Africa
Pharmaceutical Industry in South Korea
Pharmaceutical Industry in Spain
Pharmaceutical Industry in Sweden
Pharmaceutical Industry in Taiwan
Pharmaceutical Industry in the Netherlands
Pharmaceutical Industry in the United States
Pharmaceutical Industry in the United States - Porter's Five Forces St...
Pharmaceutical Industry in UK - Porter's Five Forces Strategy Analysis...
Pharmaceutical Industry in United States: Industry Analysis, Forecast,...
Pharmaceutical Industry Market Review 2008
Pharmaceutical Innovation Through Academic Alliances
Pharmaceutical Innovation: Driver of Long-Term Value
Pharmaceutical Innovation: Is It Really Rewarded?
Pharmaceutical Key Trends 2010
Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory...
Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructur...
Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Ove...
Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overvi...
Pharmaceutical Key Trends 2011 Overview - Key Strategic Trends in the ...
Pharmaceutical Licensing and Alliances in the Asia-Pacific Region - Ph...
Pharmaceutical Licensing Overview
Pharmaceutical Licensing Strategies: Best Practices in Deal-Making, Va...
Pharmaceutical Lifecycle Management: Strategy Selection and Execution
Pharmaceutical Logistics Market Map 2008
Pharmaceutical M&A in the Asia Pacific Region
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive ...
Pharmaceutical Management of Obesity
Pharmaceutical Manufacturers & Developers - Business Ratio Report
Pharmaceutical Manufacturers (Japan) - Portfolio Analysis
Pharmaceutical Manufacturers (Japan) - Portfolio Analysis
Pharmaceutical Manufacturers - Africa
Pharmaceutical Manufacturers - Algeria
Pharmaceutical Manufacturers - Americas
Pharmaceutical Manufacturers - Asia
Pharmaceutical Manufacturers - Australia
Pharmaceutical Manufacturers - Austria
Pharmaceutical Manufacturers - Belarus
Pharmaceutical Manufacturers - Belgium
Pharmaceutical Manufacturers - Bulgaria
Pharmaceutical Manufacturers - Canada
Pharmaceutical Manufacturers - Chile
Pharmaceutical Manufacturers - China
Pharmaceutical Manufacturers - Croatia
Pharmaceutical Manufacturers - Czech Republic
Pharmaceutical Manufacturers - Denmark
Pharmaceutical Manufacturers - Eastern Europe
Pharmaceutical Manufacturers - Egypt
Pharmaceutical Manufacturers - Europe
Pharmaceutical Manufacturers - Finland
Pharmaceutical Manufacturers - France
Pharmaceutical Manufacturers - Germnay
Pharmaceutical Manufacturers - Global
Pharmaceutical Manufacturers - Greece
Pharmaceutical Manufacturers - Hong Kong
Pharmaceutical Manufacturers - Hungary
Pharmaceutical Manufacturers - India
Pharmaceutical Manufacturers - Iran
Pharmaceutical Manufacturers - Ireland
Pharmaceutical Manufacturers - Israel
Pharmaceutical Manufacturers - Italy
Pharmaceutical Manufacturers - Japan
Pharmaceutical Manufacturers - Kazakhstan
Pharmaceutical Manufacturers - Kirgyzstan
Pharmaceutical Manufacturers - Latvia
Pharmaceutical Manufacturers - Lebanon
Pharmaceutical Manufacturers - Lithuania
Pharmaceutical Manufacturers - Malaysia
Pharmaceutical Manufacturers - Mexico
Pharmaceutical Manufacturers - Moldova
Pharmaceutical Manufacturers - Monaco
Pharmaceutical Manufacturers - Morocco
Pharmaceutical Manufacturers - Netherlands
Pharmaceutical Manufacturers - New Zealand
Pharmaceutical Manufacturers - Norway
Pharmaceutical Manufacturers - Poland
Pharmaceutical Manufacturers - Portugal
Pharmaceutical Manufacturers - Romania
Pharmaceutical Manufacturers - Russia
Pharmaceutical Manufacturers - Serbia
Pharmaceutical Manufacturers - Singapore
Pharmaceutical Manufacturers - Slovakia
Pharmaceutical Manufacturers - Slovenia
Pharmaceutical Manufacturers - South Africa
Pharmaceutical Manufacturers - South Korea
Pharmaceutical Manufacturers - Spain
Pharmaceutical Manufacturers - Sri Lanka
Pharmaceutical Manufacturers - Sweden
Pharmaceutical Manufacturers - Switzerland
Pharmaceutical Manufacturers - Taiwan
Pharmaceutical Manufacturers - Thailand
Pharmaceutical Manufacturers - Turkey
Pharmaceutical Manufacturers - Ukraine
Pharmaceutical Manufacturers - United Arab Emirates
Pharmaceutical Manufacturers - United Kingdom
Pharmaceutical Manufacturers - United States
Pharmaceutical Manufacturers - Uzbekistan
Pharmaceutical Manufacturers - Western Europe
Pharmaceutical Manufacturers in France - Portfolio Analysis
Pharmaceutical Manufacturing
Pharmaceutical Market 2003: A 10 Year Market Forecast
Pharmaceutical Market Access in Europe: The Barriers Keep On Rising
Pharmaceutical Market Access in Latin America
Pharmaceutical Market Access, Pricing, and Reimbursement News in the S...
Pharmaceutical Market Access, Pricing, and Reimbursement News in the T...
Pharmaceutical Market and Health Care Reform in China 2008
Pharmaceutical Market in China 2000: Market Trend and Future Analysis ...
Pharmaceutical Market in India by 2020: A Healthy Decade
Pharmaceutical Marketing
Pharmaceutical Medical Publications: Market Preparation & Strategic Su...
Pharmaceutical Mergers & Acquisitions - M&A in the Biopharmaceutical I...
Pharmaceutical Mergers and Acquisitions
|
|